Junyan Qian

Peking Union Medical College Hospital, Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Extended follow-up of CD19 CAR T-cell therapy in connective tissue disease-associated pulmonary arterial hypertension.

Extended follow-up of CD19 CAR T-cell therapy in connective tissue disease-associated pulmonary arterial hypertension.

Journal: The European respiratory journal

Published: February 23, 2026

Development of a novel meta-polygenic risk score for risk assessment and clinical manifestation prediction in systemic lupus erythematosus.

Development of a novel meta-polygenic risk score for risk assessment and clinical manifestation prediction in systemic lupus erythematosus.

Journal: RMD open

Published: September 24, 2025

CD19 CAR T-cell therapy for connective tissue disease-associated pulmonary arterial hypertension.

CD19 CAR T-cell therapy for connective tissue disease-associated pulmonary arterial hypertension.

Journal: The European respiratory journal

Published: September 18, 2025

Dual-tracer PET/CT imaging with 68Ga-DOTATATE and Al18F-NOTA-FAPI for dynamic evaluation of myocardial inflammation and fibrosis in antimitochondrial antibody-positive myositis.

Dual-tracer PET/CT imaging with 68Ga-DOTATATE and Al18F-NOTA-FAPI for dynamic evaluation of myocardial inflammation and fibrosis in antimitochondrial antibody-positive myositis.

Journal: Rheumatology and immunology research

Published: July 18, 2025

Applying Genetic Risk Score to Improve Risk Assessment of New-Onset Lupus Nephritis in Systemic Lupus Erythematosus: A Large-Scale Prospective Cohort Study.

Applying Genetic Risk Score to Improve Risk Assessment of New-Onset Lupus Nephritis in Systemic Lupus Erythematosus: A Large-Scale Prospective Cohort Study.

Journal: MedComm

Published: June 09, 2025

Impact of antiphospholipid antibodies on heart valve involvements in systemic lupus erythematosus: based on CSTAR cohort.

Impact of antiphospholipid antibodies on heart valve involvements in systemic lupus erythematosus: based on CSTAR cohort.

Journal: Lupus science & medicine

Published: May 26, 2025

Development on the Proficiency of Diagnosis and Clinical Care for Rare Diseases in Young Physicians in China.

Development on the Proficiency of Diagnosis and Clinical Care for Rare Diseases in Young Physicians in China.

Journal: Health care science

Published: May 23, 2025

Association of Rare Variants in Pulmonary Arterial Hypertension-Related Genes With a Distinct Vasculopathy Phenotype and Worse Outcomes in Patients With Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension.

Association of Rare Variants in Pulmonary Arterial Hypertension-Related Genes With a Distinct Vasculopathy Phenotype and Worse Outcomes in Patients With Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension.

Journal: Chest

Published: April 22, 2025

Rare TRAF5 coding variants in systemic lupus erythematosus patients aggravate pulmonary hypertension via endothelial dysfunction.

Rare TRAF5 coding variants in systemic lupus erythematosus patients aggravate pulmonary hypertension via endothelial dysfunction.

Journal: Innovation (Cambridge (Mass.))

Published: January 28, 2025

Activin A-Activated ALK4 Induces Pathogenic Th17-Involved Endothelial-Mesenchymal Transition in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension.

Activin A-Activated ALK4 Induces Pathogenic Th17-Involved Endothelial-Mesenchymal Transition in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: December 04, 2024

The association between STAT4 polymorphism and pulmonary arterial hypertension in Chinese patients with primary Sjögren's syndrome.

The association between STAT4 polymorphism and pulmonary arterial hypertension in Chinese patients with primary Sjögren's syndrome.

Journal: Clinical rheumatology

Published: November 11, 2024

Predictive value of pulmonary to systemic vascular resistance ratio in systemic lupus erythematosus patients with pulmonary arterial hypertension.

Predictive value of pulmonary to systemic vascular resistance ratio in systemic lupus erythematosus patients with pulmonary arterial hypertension.

Journal: Journal of hypertension

Published: November 03, 2024

Showing 1-12 of 50

Last Updated: 09/26/2026